This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
June 22, 2012 /PRNewswire-Asia-FirstCall/ -- Fuwei Films (Holding) Co., Ltd. (NASDAQ: FFHL)("Fuwei Films" or the "Company"), a manufacturer and distributor of high-quality BOPET films in
China, today announced that its subsidiary – Fuwei Films (
Shandong) Co., Ltd ("Shandong Fuwei") was certified as meeting the requirements of OHSAS 18001:2007 Occupational Health and Safety Management Systems.
OHSAS 18001 is an internationally recognized assessment specification for occupational health and safety management systems. OHSAS promotes a safe and healthy working environment by providing a framework that allows organizations to reduce the potential for accidents and improve overall performance.
Shandong Fuwei started its application last October and had conducted hazard identification, risk assessment and controls and obtained the OHSAS 18001:2007 certification this June with the term of the certificate beginning on
June 1, 2012 and ending
June 1, 2015.
The certification is instructed and conducted by SGS-CSTC Standards Technical Services Co., Ltd. ("SGC") - Beijing Office. SGS is the world's leading inspection, verification, testing and certification company.
"We are pleased to announce that we are now an OHSAS 18001 compliant manufacturing company. We believe that this demonstrates our constant efforts in improving the safety of our workplace environment and employees as well as their health. We are committed to enhancing occupational health and safety, which is vital especially for a manufacturing company," said Mr.
Xiaoan He, Chairman and CEO of the Company.
About Fuwei Films
Fuwei Films conducts its business through its wholly owned subsidiary, Fuwei Films (
Shandong) Co., Ltd. ("Shandong Fuwei"). Shandong Fuwei develops, manufactures and distributes high-quality plastic films using the biaxial oriented stretch technique, otherwise known as BOPET film (biaxially oriented polyethylene terephthalate). Fuwei Films' BOPET film is widely used to package food, medicine, cosmetics, tobacco, and alcohol, as well as in the imaging, electronics, and magnetic products industries.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are subject to risks. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission which, among other things, include competition in the BOPET film industry; growth of, and risks inherent in, the BOPET film industry in
China; uncertainty as to future profitability and our ability to obtain adequate financing for our planned capital expenditure requirements; uncertainty as to our ability to continuously develop new BOPET film products and keep up with changes in BOPET film technology; risks associated with possible defects and errors in our products including complaints and claims from clients; uncertainty as to our ability to protect and enforce our intellectual property rights; uncertainty as to our ability to attract and retain qualified executives and personnel; and uncertainty in acquiring raw materials on time and on acceptable terms, particularly in view of the volatility in the prices of petroleum products in recent years. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release. Actual results of our operations may differ materially from information contained in the forward-looking statements as a result of the risk factors.
For more information, please contact: